Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-052317

Odonate Therapeutics, Inc. · ODT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Officer — Chief Executive Officer · Director · 10% Owner
John G Lemkey
Officer — Chief Financial Officer
Period of report
Sep 24, 2018
Accepted (ET)
Sep 26, 2018 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Sep 24, 2018P10,000$20.2993A12,592,338IBy LP
Common StockF3,F2Sep 24, 2018P10,000$19.9839A12,602,338IBy LP
Common StockF4,F2Sep 25, 2018P10,000$19.6477A12,612,338IBy LP
Common StockF5,F2Sep 26, 2018P10,000$19.0664A12,622,338IBy LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses